Variant report
Variant | esv19007 |
---|---|
Chromosome Location | chr2:49653686-49662187 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577526583 | chr2:49653690-49653691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs386645914 | chr2:49653700-49653701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569414302 | chr2:49653704-49653705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs115639765 | chr2:49653707-49653708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs28391115 | chr2:49653709-49653710 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs17038785 | chr2:49653746-49653747 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs530602291 | chr2:49653759-49653760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551871316 | chr2:49653776-49653777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs67353038 | chr2:49653789-49653790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188427197 | chr2:49653801-49653802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181189490 | chr2:49653819-49653820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs146892545 | chr2:49653842-49653843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs112773722 | chr2:49653848-49653849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559750722 | chr2:49653901-49653902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530049324 | chr2:49653909-49653910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140784234 | chr2:49653913-49653914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569633674 | chr2:49653925-49653926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs144577805 | chr2:49653959-49653960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559077262 | chr2:49653960-49653961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1527886 | chr2:49653980-49653981 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs541638407 | chr2:49654020-49654021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553026248 | chr2:49654023-49654024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185888147 | chr2:49654072-49654073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566538548 | chr2:49654075-49654076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs191545228 | chr2:49654082-49654083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs369554642 | chr2:49654091-49654092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181634868 | chr2:49654131-49654132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs13399722 | chr2:49654141-49654142 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs545424064 | chr2:49654150-49654151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs55725819 | chr2:49654208-49654209 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs528212782 | chr2:49654231-49654232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138537079 | chr2:49654240-49654241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs370584640 | chr2:49654241-49654242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186854270 | chr2:49654244-49654245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs529156532 | chr2:49654250-49654251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs140146024 | chr2:49654253-49654254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1544914 | chr2:49654260-49654261 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs62165581 | chr2:49654271-49654272 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs373703498 | chr2:49654302-49654303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557587908 | chr2:49654319-49654320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112992578 | chr2:49654324-49654325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150325644 | chr2:49654349-49654350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs17038794 | chr2:49654362-49654363 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs540204040 | chr2:49654363-49654364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs576842742 | chr2:49654366-49654367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192145824 | chr2:49654381-49654382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553505183 | chr2:49654393-49654394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs138029173 | chr2:49654417-49654418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544118654 | chr2:49654424-49654425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs10181156 | chr2:49654514-49654515 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49653600-49654600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr2:49654000-49654400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr2:49654000-49655000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr2:49654000-49655200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr2:49654200-49655000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |